D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens

Neuroscience

Volumn 86, Issue 2, 1998, Pages 521-531

  Keys, A S ^a   Mark, G P ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Microdialysis; Psychostimulant; Rat; Reverse dialysis; SCH 23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; AMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; SULPIRIDE; DOPAMINE RECEPTOR BLOCKING AGENT;

ACETYLCHOLINE RELEASE; ARTICLE; CHOLINERGIC ACTIVITY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; MICRODIALYSIS; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR BINDING; SYNAPTIC TRANSMISSION; ANIMAL; DRUG EFFECT; INFUSION; KINETICS; MALE; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACETYLCHOLINE; AMPHETAMINE; ANIMALS; DOPAMINE ANTAGONISTS; INFUSIONS, PARENTERAL; KINETICS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE; TIME FACTORS;

EID: 0032152895     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00018-9     Document Type: Article

References (40)

1. Acquas E., Wilson C., Fibiger H. C. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo. J. Pharmac. exp. Ther. 281:1997;360-368.
2. Bjorklund A. and Lindvall O. (1984) Dopamine-containing systems in the CNS. In Handbook of Chemical Neuroanatomy, Classical Transmitters in the CNS (eds Bjorklund A. and Hokfelt T.), pp. 15-122. Elsevier, Amsterdam.
3. Bourland J. A., French E. D. Effects of remoxipride, an atypical antipsychotic on cocaine self-administration in the rat using fixed- and progressive-ratio schedules of reinforcement. Drug Alcoh. Depend. 40:1995;111-114.
4. Caine S. B., Heinrichs S. C., Coffin V. L., Koob G. F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692:1995;47-56.
5. Consolo S., Girotti P., Russi G., Di Chiara G. Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J. Neurochem. 59:1992;1555-1557.
6. Damsma G., De Boer P., Westerink B. H. C., Fibiger H. C. Dopaminergic regulation of striatal cholinergic interneurons. Naunyn-Schmiedeberg's Arch. Pharmac. 342:1990;523-527.
7. Damsma G., Robertson G. S., Tham C. S., Fibiger H. C. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. J. Pharmac. exp. Ther. 259:1991;1064-1072.
8. De Boer P., Abercrombie E. D. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. J. Pharmac. exp. Ther. 277:1996;775-783.
9. De Boer P., Damsma G., Schram Q., Stoof J. C., Zaagsma J., Westerink B. H. C. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmac. 345:1992;144-152.
10. De Boer P., Heeringa M. J., Abercrombie E. D. Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors. Eur. J. Pharmac. 317:1996;257-262.
11. Fage D., Scatton B. Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum. Eur. J. Pharmac. 129:1986;359-362.
12. Florin S. M., Kuczenski R., Segal D. S. Amphetamine-induced changes in behavior and caudate extracellular acetylcholine. Brain Res. 581:1992;53-58.
13. Gifford A. N., Johnson K. M. Effect of chronic cocaine treatment on D2 receptors regulating the release of dopamine and acetylcholine in the nucleus accumbens and striatum. Pharmac. Biochem. Behav. 41:1992;841-846.
14. Goeders N. E., Dworkin S. I., Smith J. E. Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex. Pharmac. Biochem. Behav. 24:1986;1429-1440.
15. Goeders N. E. and Smith J. E. (1993) Intracranial cocaine self-administration into the medial prefrontal cortex increases dopamine turnover in the nucleus accumbens. J. Pharmac. exp. Ther. 592-600.
16. Hamilton M. H., De Belleroche J. S., Gardiner I. M., Herberg L. J. Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens. Pharmac. Biochem. Behav. 25:1986;943-948.
17. Howell L. L., Byrd L. D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J. Pharmac. exp. Ther. 258:1991;178-185.
18. Hubner C. B., Moreton J. E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology. 105:1991;151-156.
19. Hurd Y. L., Weiss F., Koob G., Ungerstedt U. The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci. Lett. 109:1990;227-233.
20. Imperato A., Obinu M. C., Demontis M. V., Gessa G. L. Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors. Eur. J. Pharmac. 229:1992;265-267.
21. Imperato A., Obinu M. C., Gessa G. L. Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur. J. Pharmac. 238:1993;377-381.
22. Kawaguchi Y., Wilson C. J., Augood S. J., Emson P. C. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci. 12:1995;527-535.
23. Kiyatkin E. A., Stein E. A. Fluctuations in nucleus accumbens dopamine during cocaine self-administration behavior: an in vivo electrochemical study. Neuroscience. 64:1995;599-617.
24. Koob G. F. Neural mechanisms of drug reinforcement. Ann. N. Y. Acad. Sci. 654:1992;171-191.
25. Maldonado R., Robledo P., Chover A. J., Caine S. B., Koob G. F. D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmac. Biochem. Behav. 45:1994;239-242.
26. Mark G., Rada P., Pothos E., Hoebel B. G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum and hippocampus of freely-behaving rats. J. Neurochem. 58:1992;2269-2274.
27. Mark G. P., Schwartz D. H., Hernandez L., West H. L. and Hoebel B. G. (1991) Application of microdialysis to the study of motivation and conditioning: measurements of dopamine and serotonin in freely-behaving rats. In Microdialysis in the Neurosciences (eds Robinson T. E. and Justice J. B.), pp. 369-385. Elsevier Science Publishing, Amsterdam.
28. Phillips G. D., Robbins T. W., Everitt B. J. Bilateral intra-accumbens self-administration of D-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride. Psychopharmacology. 114:1994;477-485.
29. Pulvirenti L., Maldonado-Lopez R., Koob G. F. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res. 594:1992;327-330.
30. Rada P., Mark G., Hoebel B. G. In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. inhibition by serotonin. Brain Res. 619:1993;98-104.
31. Rada P., Mark G. P., Hoebel B. G. In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats. II. inhibition by gamma- aminobutyric acid. Brain Res. 619:1993;105-109.
32. Rada P., Pothos E., Mark G. P., Hoebel B. G. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res. 561:1991;354-356.
33. Robertson G. S., Hubert G. W., Tham C.-S., Fibiger H. C. Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetlycholine release. Eur. J. Pharmac. 219:1992;323-325.
34. Scheel-Kruger J., Arnt J. New aspects in the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia. Psychopharmacology. 2:1985;46-57.
35. Self D. W., Belluzi J. D., Kossuth S., Stein L. Self-administration of the D1 agonist SKF-82958 is mediated by D1, not D2 receptors. Psychopharmacology. 123:1996;303-306.
36. Shoaib M., Benwell M. E., Akbar M. T., Stolerman I. P., Balfour D. J. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br. J. Pharmac. 111:1994;1073-1080.
37. Spehlmann R., Stahl S. M. Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals. Lancet. 1:1976;724-726.
38. Ueda H., Sato K., Okumura F., Misu Y. L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats. Brain Res. 698:1995;213-216.
39. Wang J. Q., McGinty J. F. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience. 75:1996;43-56.
40. Weed M. R., Vanover K. E., Woolverton W. L. Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacology. 113:1993;51-52.